What are the mechanisms that are suspect for increasing incidence of osteonecrosis of the jaw in those taking bisphosphonates? Is this a significant risk? Dr. John Carey, consultant physician in internal medicine and rheumatology at Galway University Hospitals, reviews the evidence potentially modifying or increasing the risk of patients developing osteonecrosis of the jaw if they take bisphosphonates. Do patients need an oral exam before they begin taking bisphosphonates? Dr. Lee Freedman hosts.
Bisphosphonates and Osteonecrosis of the Jaw
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What are the mechanisms that are suspect for increasing incidence of osteonecrosis of the jaw in those taking bisphosphonates? Is this a significant risk? Dr. John Carey, consultant physician in internal medicine and rheumatology at Galway University Hospitals, reviews the evidence potentially modifying or increasing the risk of patients developing osteonecrosis of the jaw if they take bisphosphonates. Do patients need an oral exam before they begin taking bisphosphonates? Dr. Lee Freedman hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?